Pharmaceuticals News

The pharmaceuticals news email from Wiser has been specifically designed for anyone with an interest in the industry. This includes medical practitioners, investors and those involved in research and development. By its very nature, the pharmaceutical industry is subject to constant change. It is a research-driven industry with companies spending much of their revenues developing new medicines and vaccines. As a result patients are able to get new and more effective treatments. This is helping to increase the life expectancy of individuals in most countries. But there are challenges. The costs of the research and development can be large which puts up the price of drugs, while governments and the medical industry argue to try to keep prices as low as possible. The industry also faces challenges from alternatives, both legal (through generic drugs) and illegal (through black market economies). To follow the latest developments in this industry you should sign up for the pharmaceuticals news email from Wiser. It is the best way to find must-read articles on the topic from around the web.

Recent Pharmaceuticals News Coverage
 
Your Weekly Recommendations Monday, February 19, 2018
 
Recommended for you
Googler-founded, GV-backed cancer startup acquired for $1.9 billion by pharma giant
9to5Google • Abner Li
Arbitral award to Daiichi: SC junks Singh bros' appeal against HC verdict
Business Standard • Agencies
Roche Expands in Personalized Medicine, Oncology with $1.9B Purchase of Flatiron Health
GEN News Feed • Alex Philippidis
Reporters highlight the budget bill’s impact on older adults
Covering Health • Liz Seegert
FDA vows to combat high drug prices and companies 'gaming the system'
CNN
Will a machine pick your next medication?
Medical Xpress
Stada Looks East in Expansion Push
Bloomberg • Misha Savic
Coverage: Roche is buying Flatiron Health for $1.9 billion
Talking Biz News • Chris Roush
Roche buys cancer EHR company Flatiron Health for $1.9B
Healthcare Dive • Suzanne Elvidge
Trump’s FTC Appointee Eyes Task Force to Investigate Drug Prices
insurancejournal.com
 
Recommended for You
Cancer, Economic Policy
Googler-founded, GV-backed cancer startup acquired for $1.9 billion by pharma giant
9to5GoogleAbner Li
One particular area of investment for GV, formerly Google Ventures, is “Life Sciences & Health,” with the venture firm’s bet into the field paying off following a large acquisition. Founded by ex-Googlers, Flatiron Health was acquired yesterday (via CNBC) for $1.9 billion...
Share
Pharmaceuticals
Arbitral award to Daiichi: SC junks Singh bros' appeal against HC verdict
Business StandardAgencies
Malvinder Singh and Shivinder Singh have run out of legal options in India to avoid paying a Rs 35 billion ($546 million) award to Daiichi Sankyo after the Supreme Court dismissed their appeal against a lower court verdict. “Heard the counsels for...
Share
Cancer, Epidemiology
Roche Expands in Personalized Medicine, Oncology with $1.9B Purchase of Flatiron Health
GEN News FeedAlex Philippidis
Roche says expanding its presence in personalized medicine and oncology explains its planned $1.9 billion acquisition of Flatiron Health, a healthcare technology and services company whose offerings are designed to support cancer care providers and life science companies. Flatiron Health has developed...
Share
AARP, Affordable Care Act
Reporters highlight the budget bill’s impact on older adults
Covering HealthLiz Seegert
Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News, the Connecticut Health I-Team and other outlets. She is a senior fellow at the Center for Health Policy...
Share
Cancer, Health Insurance
FDA vows to combat high drug prices and companies 'gaming the system'
CNN
Food and Drug Administration Commissioner Scott Gottlieb said he will do everything "within my lane" to combat high drug prices and that he sees drug companies "gaming the system to try to block competition" in a multitude of ways in the marketplace....
Share
Computer Science, Epidemiology
Will a machine pick your next medication?
Medical Xpress
What once seemed like a scene from a 22nd century sci-fi movie is reality today. High speed, big data-processing computers combine artificial intelligence with human know-how to crack complex health care conditions. This deep computer analysis may unveil new patterns that could...
Share
GlaxoSmithKline plc, Pharmaceuticals
Stada Looks East in Expansion Push
BloombergMisha Savic
Targets to include smaller drug makers with niche products Stada to add more inhouse production to improve efficiency Stada Arzneimittel AG will shop around for niche drug producers in central and eastern Europe to fuel expansion plans and boost regional sales growth...
Share
Business Reporting, Cancer
Coverage: Roche is buying Flatiron Health for $1.9 billion
Talking Biz NewsChris Roush
Swiss pharmaceutical giant Roche Group is buying Flatiron Health, an Alphabet-backed cancer-focused startup founded by two former Google employees, for $1.9 billion. Christina Farr of CNBC.com had the news: Flatiron was valued at $1.2 billion when it raised its last round from...
Share
Cancer, Electronic Health Records
Roche buys cancer EHR company Flatiron Health for $1.9B
Healthcare DiveSuzanne Elvidge
Dive Brief: Swiss pharma Roche AG on Thursday snapped up oncology EHR company Flatiron Health, paying $1.9 billion to acquire the remaining 87.4% of the privately held tech company not already owned by Roche. Backed by both Roche and Alphabet's venture arm...
Share
Business Ethics, Financial Regulatory Bodies
Trump’s FTC Appointee Eyes Task Force to Investigate Drug Prices
insurancejournal.com
President Donald Trump’s nominee to lead the Federal Trade Commission said he’s “very concerned” about price increases for prescription drugs and will explore forming a task force to monitor whether higher prices are due to anti-competitive conduct. Joe Simons, a Washington antitrust...
Share